Close

News

Schreiner MediPharm’s Pharma-Comb IL Label Supports Innovative Clinical Cancer Trial Utilizing Oncolytic Viruses

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, is supplying its durable Pharma-Comb IL Label solution to a company whose clinical trial cancer medication requires low-temperature storage and pre-administration thawing, making marking and documentation particularly challenging. Various...

DoKaSch Temperature Solutions appoints Sales & Business Development Manager for China

DoKaSch Temperature Solutions is strengthening its foothold in Asia. The provider of temperature-controlled packaging solutions has appointed Emily Tang as Sales & Business Development Manager for China. Based in China, Tang has been catering to the needs of customers...

ProPharma Announces New Office in Medicon Village – Lund, Sweden

ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and a portfolio company of Odyssey Investment Partners, is proud to announce its upcoming move to a new office location in Lund, Sweden, effective June 1, 2023. Known for its...

Quanticate announces strategic partnership with KPS Life

Quanticate, a global biometric clinical research organization, is pleased to announce its strategic partnership with KPS Life, a US-based provider of Functional Service Provision solutions focused on clinical operations and clinical monitoring oversight. This partnership will enable Biotech and Pharma...

Future-Proofing The Pharma Supply Chain – Top Ten Trends

The pharma sector happens to be consistently evolving, and one of the most critical components of transformation is within the supply chain. The significance of a well-operational supply chain has never been more relevant than in the current years....

WHO & Republic of Korea Tie-Up For Biomanufacturing Training

The World Health Organisation as well as the Republic of South Korea have gone ahead and inked a MoU so as to establish a worldwide training hub when it comes to biomanufacturing. The worldwide training centre will go on...

China Fines Pharmaceutical Firms For Monopolistic Behaviour

Two pharmaceutical companies for monopolistic behaviour have been penalized by the Chinese regulator. It has put a fine on Grand Pharmaceuticals for 136 million yuan, which is equivalent to $19.68 million, and has also confiscated 149 million of revenue...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »